Wells Fargo & Company Cocrystal Pharma, Inc. Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.27 - $3.6 $2 - $32	-9 Reduced 0.89%	1,006 $0
Q2 2022 Aug 12, 2022	BUY	$0.38 - $0.55 $19 - $27	50 Added 5.18%	1,015 $0
Q1 2022 May 16, 2022	BUY	$0.48 - $0.71 $0 - $1	2 Added 0.21%	965 $0
Q3 2021 Nov 15, 2021	SELL	$1.01 - $1.25 $1,199 - $1,485	-1,188 Reduced 55.23%	963 $1,000
Q2 2021 Aug 16, 2021	BUY	$1.08 - $2.14 $1,518 - $3,008	1,406 Added 188.72%	2,151 $4,000
Q1 2021 May 13, 2021	SELL	$1.3 - $2.35 $2 - $4	-2 Reduced 0.27%	745 $1,000
Q4 2020 Feb 09, 2021	BUY	$0.8 - $2.16 $376 - $1,015	470 Added 169.68%	747 $1,000
Q3 2020 Nov 05, 2020	BUY	$0.86 - $2.36 $38 - $106	45 Added 19.4%	277 $0
Q2 2020 Aug 13, 2020	BUY	$0.7 - $1.58 $65 - $146	93 Added 66.91%	232 $0
Q1 2020 May 14, 2020	BUY	$0.48 - $2.19 $66 - $304	139 New	139 $0

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $14.6M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.